IGUAKO Capital is a work of institutional fiction by the Iguako Institute for Applied Unreality. No financial services are offered, no accounts exist and nothing here is an offer, a contract or advice.About this work
George Town · 36 cities · English Domiciles Documents Iguako Network Site Index

Global Network · Latin America

Mexico City

Mexico City covers manufacturing. Three positions are held through IGUAKO Farmacéutica México, S. de R.L. de C.V.: a sterile-injectable plant, a generics manufacturer and a contract manufacturer that supplies regulated markets to the north. Latitude Manufactura Estructurada, S.A. de C.V. had US$14 million of equipment and receivables facilities outstanding at 30 June 2026. Six people work from Reforma Pavilion.

Country
Mexico
Region
Latin America
Type
Office
Opened
2024
People
6
Building
Level 15, Reforma Pavilion, Mexico City
Domicile
Mexico

Diligence in this market is technical before it is financial. The office reviews plant licences, inspection histories, batch records and supply agreements before a position is put to the Investment Committee. One of the six people is a regulatory-affairs researcher, and the register of the eleven manufacturing licences behind the positions is kept here. A manufacturing failure is treated as a credit event and provisioned as one.

US$6 million of the client portfolio is attributed to Mexico, which understates the office. Its value to the group is the sight it gives of pharmaceutical and specialty-materials supply chains that feed positions taken in other regions. The 2031 phase of Programme Latitude expands the office and its coverage of the northern manufacturing corridor.

Functions

  • Coverage of pharmaceutical manufacturing and specialty-materials supply chains
  • Management of the three pharmaceutical manufacturing positions
  • Commercial Finance origination for Mexican suppliers
  • Regulatory and quality diligence on manufacturing counterparties

Office lead
Valentina Ochoa-Brightwater, Head of Office, Mexico City